Testicular Cancer Foundation (EIN 271348551) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2009

Legal Domicile

Principal Officer

KENNETH KANE

Phone

8553908231

Tax Period

2024-01-01 to 2024-12-31

Testicular Cancer Foundation, founded in 2009, is a small nonprofit in the Human Services sector that reported $184K in total revenue in fiscal year 2024. Revenue fell 72% from the prior year — a significant decline worth monitoring. Expenses of $273K exceeded revenue, resulting in a 48% operating deficit.

Mission

PROVIDE EDUCATION AND SUPPORT TO YOUNG MEN TO RAISE AWARENESS ABOUT TESTICULAR CANCER THE MOST COMMONLY DIAGNOSED CANCER AMONG MALES AGES 15-35.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $186,493

Program Service Revenue $0

Investment Income $-2,295

Other Revenue $0

TOTAL REVENUE $184,198

Expense Breakdown

Grants Paid $0

Salaries & Benefits $158,782

Fundraising Expenses $0

Program Expenses $272,961

Other Expenses $114,179

TOTAL EXPENSES $272,961

Year-over-Year Comparison

	2024	2023	Change
Revenue	$184,198	$657,326	-0.7%
Expenses	$272,961	$281,790	0.0%
Net Income	$-88,763	$375,536	-1.2%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$144,917

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Connor O'Leary	Chief Mission Officer	40.00	Officer	$121,917	$0	$121,917
Kenneth J Kane	CEO	40.00	Officer	$23,000	$0	$23,000
Matthew Ferstler	Chairman	0.00	Officer Director	$0	$0	$0
Dennis Ferstler	Director	0.00	Officer Director	$0	$0	$0
Justin Lindenmuth	President	0.00	Officer Director	$0	$0	$0
Steve Gavers	Director	0.00	Officer Director	$0	$0	$0
Matthew Froestad	Director	0.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$184,198	$272,961	$412,098	$-88,763
2023	$657,326	$281,790	$492,462	$375,536
2022	$261,544	$310,949	$117,167	$-49,405
2021	$228,336	$259,632	$163,533	$-31,296
2020	$260,630	$161,003	$221,725	$99,627
2019	$161,607	$181,323	$100,798	$-19,716
2018	$132,633	$214,800	$121,313	$-82,167

Testicular Cancer Foundation